State Street Corp Adaptive Biotechnologies Corp Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, State Street Corp holds 2,551,785 shares of ADPT stock, worth $13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,551,785
Previous 2,502,900 1.95%
Holding current value
$13 Million
Previous $9.06 Million 44.21%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.37 - $5.12 $164,742 - $250,291
48,885 Added 1.95%
2,551,785 $13.1 Million
Q2 2024

Aug 14, 2024
SELL
$2.34 - $3.96 $415,691 - $703,478
-177,646 Reduced 6.63%
2,502,900 $9.06 Million
Q1 2024

May 15, 2024
BUY
$2.88 - $4.8 $256,011 - $426,686
88,893 Added 3.43%
2,680,546 $8.6 Million
Q4 2023

Feb 14, 2024
BUY
$3.46 - $5.33 $195,877 - $301,741
56,612 Added 2.23%
2,591,653 $12.7 Million
Q3 2023

Nov 14, 2023
SELL
$5.07 - $8.44 $48,606 - $80,914
-9,587 Reduced 0.38%
2,535,041 $13.8 Million
Q2 2023

Aug 14, 2023
SELL
$6.19 - $8.78 $144,932 - $205,574
-23,414 Reduced 0.91%
2,544,628 $17.1 Million
Q1 2023

May 15, 2023
BUY
$7.8 - $10.11 $519,394 - $673,214
66,589 Added 2.66%
2,568,042 $22.7 Million
Q4 2022

Feb 14, 2023
BUY
$6.26 - $9.34 $156,612 - $233,668
25,018 Added 1.01%
2,501,453 $19.1 Million
Q3 2022

Nov 15, 2022
BUY
$6.5 - $12.67 $890,831 - $1.74 Million
137,051 Added 5.86%
2,476,435 $17.6 Million
Q2 2022

Aug 15, 2022
BUY
$6.4 - $14.73 $2.98 Million - $6.85 Million
464,913 Added 24.8%
2,339,384 $18.9 Million
Q1 2022

May 16, 2022
BUY
$10.12 - $28.9 $2.47 Million - $7.04 Million
243,581 Added 14.94%
1,874,471 $26 Million
Q4 2021

Feb 14, 2022
BUY
$25.17 - $36.85 $2.65 Million - $3.87 Million
105,132 Added 6.89%
1,630,890 $45.8 Million
Q3 2021

Nov 15, 2021
BUY
$30.02 - $39.87 $2.97 Million - $3.94 Million
98,837 Added 6.93%
1,525,758 $51.9 Million
Q2 2021

Aug 16, 2021
BUY
$32.22 - $44.59 $15.3 Million - $21.1 Million
473,378 Added 49.64%
1,426,921 $58.3 Million
Q1 2021

May 17, 2021
SELL
$37.26 - $67.74 $66,732 - $121,322
-1,791 Reduced 0.19%
953,543 $38.4 Million
Q4 2020

Feb 16, 2021
BUY
$45.01 - $65.47 $1.56 Million - $2.28 Million
34,767 Added 3.78%
955,334 $56.5 Million
Q3 2020

Nov 10, 2020
BUY
$35.79 - $48.81 $3.84 Million - $5.23 Million
107,210 Added 13.18%
920,567 $44.8 Million
Q2 2020

Aug 14, 2020
BUY
$24.95 - $48.38 $2.48 Million - $4.81 Million
99,461 Added 13.93%
813,357 $39.4 Million
Q1 2020

May 11, 2020
BUY
$16.96 - $34.16 $12.1 Million - $24.4 Million
713,896 New
713,896 $19.8 Million

Others Institutions Holding ADPT

# of Institutions
201
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $726M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email